tirzepatide perimenopause If weight loss slows on during perimenopause, that isn’t “noncompliance.”, It’s biology colliding with a system that wasn’t built to explain it., #obesitydoctor #womenshealth One of the biggest misconceptions

Most patients report initial improvements in pain levels within 2-4 weeks of starting peptide therapy

Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis

Because AOD-9604 does not bind to growth hormone receptors in liver, muscle, or adipose tissue, it cannot trigger the metabolic pathways that mediate growth hormones counter-regulatory effects on glucose metabolism

This route offers pharmaceutical-grade purity and potency, concentrations well above OTC products (typically 2 to 10 percent or more versus cosmetic-grade 0.01 to 1 percent), physician evaluation before prescribing, ongoing medical oversight, and full FDA compliance

Animal studies have raised concerns including smaller fetuses, delayed bone development, skeletal changes and pregnancy loss, especially when mothers lose a significant amount of weight during early fetal development